Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Beta Bionics, Inc.BBNX · Entity 2350 | Director | May 21, 2026 | May 26, 2026 |
| DELCATH SYSTEMS, INC.DCTH · Entity 5387 | Director · CHIEF EXECUTIVE OFFICER | March 02, 2026 | March 03, 2026 |
| Vericel CorpVCEL · Entity 4481 | CFO and VP, Corp. Development | April 01, 2020 | April 03, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Beta Bionics, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,509 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 16,965 · Balance 33,509 F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
DELCATH SYSTEMS, INC.
Report date March 02, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 342,034 |
Reported balance
After 2026-03-02 transaction · row 1
1 source rowRow 1 · 2026-03-02 · Purchase · Acquired 11,200 · Balance 342,034 |
Vericel Corp
Report date April 01, 2020 · Filed April 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 253,865 |
Last balance in matching sequence
After 2020-04-01 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
7 source rowsRow 1 · 2020-04-01 · Exercise / conversion · Acquired 10,000 · Balance 172,708 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 2 · 2020-04-01 · Exercise / conversion · Acquired 58,519 · Balance 231,227 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 3 · 2020-04-01 · Exercise / conversion · Acquired 4,375 · Balance 235,602 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 4 · 2020-04-01 · Exercise / conversion · Acquired 3,090 · Balance 238,692 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 5 · 2020-04-01 · Exercise / conversion · Acquired 1,875 · Balance 240,567 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 6 · 2020-04-01 · Exercise / conversion · Acquired 7,673 · Balance 248,240 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Row 7 · 2020-04-01 · Exercise / conversion · Acquired 5,625 · Balance 253,865 F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2026-02-09 | Direct | 0 |
Reported balance
After 2020-04-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2020-04-01 · Exercise / conversion · Disposed 10,000 · Balance 0 F2: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.75 · Expires 2027-02-08 | Direct | 25,173 |
Reported balance
After 2020-04-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2020-04-01 · Exercise / conversion · Disposed 4,375 · Balance 25,173 F3: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. F4: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.02 · Expires 2025-01-05 | Direct | 0 |
Reported balance
After 2020-04-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2020-04-01 · Exercise / conversion · Disposed 58,519 · Balance 0 F5: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.20 · Expires 2028-02-07 | Direct | 95,035 |
Reported balance
After 2020-04-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2020-04-01 · Exercise / conversion · Disposed 3,090 · Balance 95,035 F6: These options, representing the right to purchase a total of 100,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2027-05-22 | Direct | 13,125 |
Reported balance
After 2020-04-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2020-04-01 · Exercise / conversion · Disposed 1,875 · Balance 13,125 F7: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. F8: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.75 · Expires 2027-02-08 | Direct | 17,500 |
Reported balance
After 2020-04-01 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2020-04-01 · Exercise / conversion · Disposed 7,673 · Balance 17,500 F3: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. F4: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.65 · Expires 2027-05-22 | Direct | 7,500 |
Reported balance
After 2020-04-01 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2020-04-01 · Exercise / conversion · Disposed 5,625 · Balance 7,500 F7: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. F8: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted.
F3: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted.
F4: These transactions relate to the 70,000 stock options granted to Mr. Michel on February 8, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 17,500.
F5: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted.
F6: These options, representing the right to purchase a total of 100,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted.
F7: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company.
F8: These transaction relate to the 30,000 stock options granted to Mr. Michel on May 22, 2017. The remaining beneficially owned stock option (right to buy) after both transactions is 7,500.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2018 Filed Nov 14, 2018 21:03 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 15,000 | $1.95 | $29,250.00 |
DisclosureSEC source: 0001593968-18-001444 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-18-001339 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:05 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 15,000 | $12.65 | $189,750.00 |
DisclosureSEC source: 0001593968-18-001339 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,960 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| October 15, 2018 Filed Oct 17, 2018 20:05 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 15,000 | $1.95 | $29,250.00 |
DisclosureSEC source: 0001593968-18-001339 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 17:57 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-18-001201 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 80,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 17:57 UTC | Vericel Corp VCEL · Entity 4481 | SaleCommon Stock | 15,000 | $12.35 | $185,250.00 |
DisclosureSEC source: 0001593968-18-001201 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,960 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 17:57 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 15,000 | $1.95 | $29,250.00 |
DisclosureSEC source: 0001593968-18-001201 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 18:50 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 67,481 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001179110-18-010244 · edgar.xml · derivative · entry 4 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,519 Underlying: Common Stock · 67,481 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options, representing a right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments following January 5, 2015, which was the date on which the option was granted. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 18:50 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.36 | $0.00 |
DisclosureSEC source: 0001179110-18-010244 · edgar.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2024-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options, representing a right to purchase a total of 45,000 shares, were granted on June 11, 2014, with 25% becoming exercisable on June 11, 2015 and 75% becoming exercisable in twelve equal quarterly installments. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 18:50 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 67,481 | $3.02 | $203,792.62 |
DisclosureSEC source: 0001179110-18-010244 · edgar.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 18:50 UTC | Vericel Corp VCEL · Entity 4481 | Exercise / conversionCommon Stock | 45,000 | $4.36 | $196,200.00 |
DisclosureSEC source: 0001179110-18-010244 · edgar.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 16:10 UTC | Vericel Corp VCEL · Entity 4481 | GrantOption (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001593968-18-000321 · primary_01.xml · derivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-07 F1 · derivative.exercise_date: These options shall begin vesting on February 7, 2018 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| December 31, 2017 Filed Feb 13, 2018 17:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 2,333 | $4.63 | $10,807.62 |
DisclosureSEC source: 0001104659-18-008853 · a5.xml · nonDerivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,697 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2017 Filed Feb 13, 2018 17:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 1.538 | $2.81 | $4.31 |
DisclosureSEC source: 0001104659-18-008853 · a5.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,364 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 30, 2017 Filed Feb 13, 2018 17:15 UTC | Vericel Corp VCEL · Entity 4481 | GrantCommon Stock | 2,115 | $2.38 | $5,033.70 |
DisclosureSEC source: 0001104659-18-008853 · a5.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,826 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 22, 2017 Filed May 24, 2017 18:01 UTC | Vericel Corp VCEL · Entity 4481 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-17-000713 · primary_01.xml · derivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: VCEL · 30,000 shares Expires 2027-05-22 F1 · derivative.exercise_date: These options shall begin vesting on February 8, 2017 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 16:26 UTC | Vericel Corp VCEL · Entity 4481 | GrantOption (right to buy) · Derivative | 31,702 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-17-000253 · primary_01.xml · derivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,702 Underlying: VCEL · 31,702 shares Expires 2027-02-08 F1 · derivative.exercise_date: These options vest quarterly over four years commencing on the grant date. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 16:26 UTC | Vericel Corp VCEL · Entity 4481 | GrantOption (right to buy) · Derivative | 38,298 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-17-000253 · primary_01.xml · derivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,298 Underlying: VCEL · 38,298 shares Expires 2027-02-08 F1 · derivative.exercise_date: These options vest quarterly over four years commencing on the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.